Results 191 to 200 of about 23,157 (220)

Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study

HIV Medicine, 2019
Arturo Ciccullo, Giordano Madeddu, Stefano Rusconi   +2 more
exaly  

Emtricitabine

2016
openaire   +1 more source

Emtricitabine: a new nucleoside analogue for once-daily antiretroviral therapy

Expert Opinion on Investigational Drugs, 2004
Pedro Cahn
exaly  

Emtricitabine/lamivudine

Reactions Weekly, 2013
openaire   +1 more source

Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Atripla®)

Drugs, 2012
Deeks Emma D, Perry Caroline M, Emma D Deeks   +2 more
exaly  

Emtricitabine

2009
openaire   +1 more source

Emtricitabine/vinblastine

Reactions Weekly, 2013
openaire   +1 more source

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide: A Review in HIV-1 Infection

Drugs, 2016
Sarah Greig, Greig Sarah L, Deeks Emma D   +2 more
exaly  

Emtricitabine/tenofovir

Reactions Weekly, 2010
openaire   +1 more source

Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: A two-year study

Journal of Hepatology, 2005
Robert Gish, , TERESA L Wright
exaly